MimeCure Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $3.52M

  • Investors
  • 6

MimeCure General Information

Description

Operator of regenerative medicine technology intended to treat chronic lung diseases through tissue regeneration. The company offers therapies focused on regenerating alveolar epithelial cells and lung tissue, enabling patients with chronic lung diseases to improve lung function and disease management.

Contact Information

Website
www.mimecure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hemstukken 19
  • 9761 KM Eelde
  • Netherlands
+31 06
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • Hemstukken 19
  • 9761 KM Eelde
  • Netherlands
+31 06

MimeCure Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MimeCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 12-May-2026 $3.52M Completed Pre-Clinical Trials
4. Accelerator/Incubator 03-Feb-2026 Completed Pre-Clinical Trials
3. Early Stage VC 13-Nov-2024 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Stealth
1. University Spin-Out 01-Apr-2024 Completed Stealth
To view MimeCure’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

MimeCure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MimeCure Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Addington Investment Group Venture Capital Minority
Apsara Investments Venture Capital Minority
Hollandbio Corporation
Pharma Connect Capital Venture Capital Minority
University of Groningen University
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

MimeCure FAQs

  • When was MimeCure founded?

    MimeCure was founded in 2024.

  • Where is MimeCure headquartered?

    MimeCure is headquartered in Eelde, Netherlands.

  • What is the size of MimeCure?

    MimeCure has 2 total employees.

  • What industry is MimeCure in?

    MimeCure’s primary industry is Drug Discovery.

  • Is MimeCure a private or public company?

    MimeCure is a Private company.

  • What is MimeCure’s current revenue?

    The current revenue for MimeCure is .

  • How much funding has MimeCure raised over time?

    MimeCure has raised $4.12M.

  • Who are MimeCure’s investors?

    Addington Investment Group, Apsara Investments, Hollandbio, Pharma Connect Capital, and University of Groningen are 5 of 6 investors who have invested in MimeCure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process